4//SEC Filing
Nusse Roeland 4
Accession 0000914190-21-000308
CIK 0000842023other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 5:13 PM ET
Size
17.8 KB
Accession
0000914190-21-000308
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Nusse Roeland
Director
Transactions
- Sale
Common Stock
2021-08-23$481.52/sh−4,000$1,926,065→ 6,765 total - Exercise/Conversion
Common Stock
2021-08-23$70.35/sh+4,000$281,400→ 10,765 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-23−4,000→ 0 totalExercise: $70.35From: 2011-10-27Exp: 2021-10-26→ Common Stock (4,000 underlying)
Holdings
- 3,985
Stock Option (right to buy)
Exercise: $101.19From: 2017-10-26Exp: 2026-10-27→ Common Stock (3,985 underlying) - 4,000
Stock Option (right to buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 1,507
Stock Option (right to buy)
Exercise: $255.69Exp: 2030-10-29→ Common Stock (1,507 underlying) - 2,011
Stock Option (right to buy)
Exercise: $201.64From: 2020-10-24Exp: 2029-10-24→ Common Stock (2,011 underlying) - 4,000
Stock Option (right to buy)
Exercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying) - 4,260
Stock Option (right to buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 3,125
Stock Option (right to buy)
Exercise: $125.05From: 2018-10-25Exp: 2027-10-26→ Common Stock (3,125 underlying) - 1,898
Stock Option (right to buy)
Exercise: $179.84From: 2019-10-24Exp: 2028-10-25→ Common Stock (1,898 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne's 2021 annual meeting of shareholders.
Documents
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001492695
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 5:13 PM ET
- Size
- 17.8 KB